- Pathological features of vessel co-option versus sprouting angiogenesis(2019)
Auteurs: Emily Latacz, Elisabetta Caspani, Raymond Barnhill, Claire Lugassy, Cornelis Verhoef, Dirk Grunhagen, Steven Van Laere, Carlos Fernandez Moro, Marco Gerling, Marie Dirix, et al.
- The circular RNome of primary breast cancer(2019)
Auteurs: Marcel Smid, Saskia M. Wilting, Katharina Uhr, F. German Rodriguez-Gonzalez, Vanja de Weerd, Wendy J. C. Prager-Van der Smissen, Michelle van der Vlugt-Daane, Anne van Galen, Serena Nik-Zainal, Adam Butler, et al.
Pagina's: 356 - 366
- TP53 outperforms other androgen receptor biomarkers to predict abiraterone or enzalutamide outcome in metastatic castration-resistant prostate cancer(2019)
Auteurs: Bram De Laere, Steffi Oeyen, Markus Mayrhofer, Tom Whitington, Pieter-Jan van Dam, Peter Van Oyen, Christophe Ghysel, Jozef Ampe, Piet Ost, Wim Demey, et al.
Pagina's: 1766 - 1773
- Characterization of an immunocompetent intraductal mouse model for triple-negative breast cancer(2019)
Auteurs: Jonas Steenbrugge, Evelyne Meyer, Steven Van Laere
Aantal pagina's: 272
- The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC)(2019)
Auteurs: Massimo Cristofanilli, Jean-Yves Pierga, James Reuben, Alfred Rademaker, Andrew A. Davis, Dieter Peeters, Tanja Fehm, Franco Nole, Rafael Gisbert-Criado, Dimitrios Mavroudis, et al.
Pagina's: 39 - 45
- Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression(2019)
Auteurs: Christophe Van Berckelaer, Charlotte Rypens, Peter Van Dam, L. Pouillon, M. Parizel, Kelly Schats, Mark M. Kockx, Wiebren Tjalma, Peter Vermeulen, Steven Van Laere, et al.
- Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer(2018)
Auteurs: Bram De Laere, Steffi Oeyen, Peter Van Oyen, Christophe Ghysel, Jozef Ampe, Pieter Ost, Wim Demey, Lucien Hoekx, Dirk Schrijvers, Barbara Brouwers, et al.
Pagina's: 435 - 445
- Multidisciplinary molecular tumour board(2018)
Auteurs: Christian Rolfo, Paolo Manca, Roberto Salgado, Peter Van Dam, Andreia Machado Coelho, Jose Ferri Gandia, Annemie Rutten, Willem Lybaert, Joanna Vermeij, Thomas Gevaert, et al.
- Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype(2018)
Auteurs: Kenichi Harano, Ying Wang, Bora Lim, Robert S. Seitz, Stephan W. Morris, Daniel B. Bailey, David R. Hout, Rachel L. Skelton, Brian Z. Ring, Hiroko Masuda, et al.
- Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy(2018)
Auteurs: Pieter-Jan van Dam, Sofie Daelemans, Elizabeth Ross, Yannick Waumans, Steven Van Laere, Emily Latacz, Roanne Van Steen, Christel De Pooter, Mark Kockx, Luc Dirix, et al.
Pagina's: 86 - 93
